Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 7;35(2):361-375.e9.
doi: 10.1016/j.cmet.2022.12.013. Epub 2023 Jan 17.

Fatty acid overproduction by gut commensal microbiota exacerbates obesity

Affiliations
Free article

Fatty acid overproduction by gut commensal microbiota exacerbates obesity

Tadashi Takeuchi et al. Cell Metab. .
Free article

Abstract

Although recent studies have highlighted the impact of gut microbes on the progression of obesity and its comorbidities, it is not fully understood how these microbes promote these disorders, especially in terms of the role of microbial metabolites. Here, we report that Fusimonas intestini, a commensal species of the family Lachnospiraceae, is highly colonized in both humans and mice with obesity and hyperglycemia, produces long-chain fatty acids such as elaidate, and consequently facilitates diet-induced obesity. High fat intake altered the expression of microbial genes involved in lipid production, such as the fatty acid metabolism regulator fadR. Monocolonization with a FadR-overexpressing Escherichia coli exacerbated the metabolic phenotypes, suggesting that the change in bacterial lipid metabolism is causally involved in disease progression. Mechanistically, the microbe-derived fatty acids impaired intestinal epithelial integrity to promote metabolic endotoxemia. Our study thus provides a mechanistic linkage between gut commensals and obesity through the overproduction of microbe-derived lipids.

Keywords: Lachnospiraceae; gut microbiome; metabolic endotoxemia; microbial metabolite; obesity; tight junction; trans-fatty acid.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests K.K. and T.F. are employees of Ajinomoto Co., Inc. This study is supported in part by a research fund from Ajinomoto Co., Inc. K.K. is a co-inventor on a patent application relating to FI (WO2022/158550A1).

Publication types

LinkOut - more resources